Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CELIAC DISEASE, SUSCEPTIBILITY TO, 3 (finding)
|
1 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 0 | ||||||||
HASHIMOTO THYROIDITIS, SUSCEPTIBILITY TO
|
1 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 0 | ||||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.860 | 0.800 | 10 | 2007 | 2019 | |||||
Rheumatoid Arthritis
|
2387 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.850 | 0.818 | 11 | 2008 | 2019 | |||||
Autoimmune thyroid disease (AITD)
|
54 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.030 | 1.000 | 3 | 2009 | 2014 | |||||
Graves Disease
|
352 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||
Primary biliary cirrhosis
|
667 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.050 | 1.000 | 5 | 2010 | 2017 | |||||
Autoimmune Diseases
|
428 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.810 | 1.000 | 3 | 2010 | 2019 | |||||
Asthma
|
1536 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.020 | 1.000 | 2 | 2010 | 2016 | |||||
Inflammatory Bowel Diseases
|
605 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Autoantibody measurement
|
52 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Childhood Osteosarcoma
|
151 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Immune System Diseases
|
116 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Multiple Sclerosis
|
1022 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Osteosarcoma
|
178 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Osteosarcoma of bone
|
151 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Drug-Induced Liver Disease
|
29 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Ewings sarcoma
|
25 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Fatigue
|
67 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
SVEINSSON CHORIORETINAL ATROPHY
|
30 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Chronic kidney disease stage 5
|
194 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Kidney Failure, Chronic
|
425 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Thyroid Diseases
|
26 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.030 | 0.667 | 3 | 2015 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.020 | 1.000 | 2 | 2015 | 2018 |